Navigation Links
Knee Implant Market Booming in China
Date:1/10/2008

s both metal and polyethylene components.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

akrohn@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Nanowire coating for bone implants, stents
2. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
3. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
4. Implantable device designed to detect, stop seizures under study at MCG
5. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
6. Bone-growing nanomaterial could improve orthopaedic implants
7. RFID Implant Cancer Questions Concern Patients
8. GrantAdler Shipping Novel Implantable Vascular Access Port
9. SBi Launches rHead(TM) Lateral Radial Head Implant and rHead(TM) Plating Systems to Expand its Elbow Management System
10. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
11. TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 The following is being released ... Remarks by: Vera Rulon, MS, RHIT, CCS, FAHIMA ... everyone and thank you joining us... ,, On behalf ... pleasure to introduce our next chief executive officer, Doctor ... on a nationwide search for someone who we ...
(Date:12/15/2009)... A new study published by The University of ... for paid and unpaid work report higher average measures ... family models. , The ,shared roles, category, where each ... the total unpaid work, is a growing category that ... Couples are more likely to be in a shared ...
(Date:12/15/2009)... users to control the volume without compromising sound-quality or comfort. ... ... 15, 2009 -- EarPeace ( www.earpeace.com ) is redefining hearing ... in three different skin-tone colors. "As a big fan of ... I was looking for a way to continue my active ...
(Date:12/15/2009)... safer than wood fiber , , TUESDAY, Dec. 15 (HealthDay News) ... in a fall are much lower on playgrounds with granite ... research has found. , Researchers at the Hospital for Sick ... surfaces of either granite sand or engineered wood fiber. Their ... . , The risk of a broken arm resulting from ...
(Date:12/15/2009)... PALM CITY, Fla., Dec. 15 Connectyx ... today that it has moved to a higher ... Current Information). The higher move positions Connectyx ... available. http://www.pinksheets.com/content/doc/ps/Disclosure/Guidelines/2.pdf ,, Connectyx President Ronn ... move as part of our efforts to become ...
Breaking Medicine News(10 mins):Health News:Dowling Press Availability Tuesday, December 15, 2009 / 10:00 a.m. CST 2Health News:EarPeace Introduces Elegant, High-fidelity Hearing Protection Solution 2Health News:Connectyx Attains 'Current Listing' Status on Pink Sheets Exchange 2Health News:Connectyx Attains 'Current Listing' Status on Pink Sheets Exchange 3
... CAMBRIDGE, Mass. An MIT research teams latest finding suggests ... more complicated than previously thought. , In a study published ... 13, MIT scientists report that adult stem cells produced in ... connectionsmaking it impossible for a neural stem cell originating in ...
... women faced with an aggressive and difficult to diagnose ... and can be lethal in six to nine months. ... computed tomography (FDG-PET/CT), radiologists and physicists are able to ... study presented today at the annual meeting of the ...
... drugs used to lower cholesterol, are among the most ... patients, accompanying side effects of muscle weakness and pain ... to debilitating and even life-threatening damage. , Now a ... Center (BIDMC), helps explain the source of these problems. ...
... are improving the chances,of women faced with an ... Inflammatory breast cancer spreads quickly and can be ... fluorodeoxyglucose positron emission,tomography combined with computed tomography (FDG-PET/CT), ... of cancer earlier, according to a,study presented today ...
... Global AIDS,Alliance Fund responded to the plan on HIV/AIDS ... Paul Zeitz, Executive Director of the Global AIDS Alliance ... will discuss the,issue further on a conference call for ... see Senator Clinton,s plan of action on HIV/AIDS. I,read ...
... 27 Despite the certificate of,occupancy, substantial hidden ... moving into newly constructed buildings. A new,program introduced ... a leading,commissioning firm to help., Even though ... a variety of hidden issues and costs can ...
Other Medicine News:Health News:MIT: Stem-cell therapies for brain more complicated than thought 2Health News:MIT: Stem-cell therapies for brain more complicated than thought 3Health News:PET/CT brings new hope to patients with deadly form of breast cancer 2Health News:Scientists identify gene responsible for statin-induced muscle pain 2Health News:Scientists identify gene responsible for statin-induced muscle pain 3Health News:PET/CT Brings New Hope to Patients With Deadly Form of Breast Cancer 2Health News:PET/CT Brings New Hope to Patients With Deadly Form of Breast Cancer 3Health News:Senator Clinton's Plan 'The Kind of Leadership We Need on AIDS' 2Health News:Hidden Costs Plague Owners Occupying Newly Constructed Buildings; New Program Can Help Avoid Major Issues 2Health News:Hidden Costs Plague Owners Occupying Newly Constructed Buildings; New Program Can Help Avoid Major Issues 3
(Date:12/15/2009)... -- Dynatronics Corporation (Nasdaq: DYNT ... agreement to provide therapy equipment and rehab supplies ... network of physical, occupational and speech therapy clinics. ... Therapy Providers," said Larry K. Beardall, executive vice ... vast network of 1,100 clinics is the largest ...
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... Pipeline Analysis and Market Forecasts to ... ,, Systemic Lupus Erythematosus - ... to 2015 ,, Summary ...
(Date:12/15/2009)... Dec. 15 Waters Corporation (NYSE: ... Vision Publisher(TM) (v.7.1 SR4), an electronic laboratory notebook ... (SDMS), a secure electronic repository that stores and ... centralized database and is used to boost efficiency ... with the SAFE-BioPharma digital identity and signature standard. ...
Breaking Medicine Technology:Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc. 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 8Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6Zeus Expands International Support With New Hires 13350 1Zeus Expands International Support With New Hires 13350 2West Announces Second Quarter 2009 Results 53596 1West Announces Second Quarter 2009 Results 53596 2West Announces Second Quarter 2009 Results 53596 3West Announces Second Quarter 2009 Results 53596 4West Announces Second Quarter 2009 Results 53596 5West Announces Second Quarter 2009 Results 53596 6West Announces Second Quarter 2009 Results 53596 7West Announces Second Quarter 2009 Results 53596 8West Announces Second Quarter 2009 Results 53596 9West Announces Second Quarter 2009 Results 53596 10West Announces Second Quarter 2009 Results 53596 11West Announces Second Quarter 2009 Results 53596 12West Announces Second Quarter 2009 Results 53596 13West Announces Second Quarter 2009 Results 53596 14West Announces Second Quarter 2009 Results 53596 15West Announces Second Quarter 2009 Results 53596 16West Announces Second Quarter 2009 Results 53596 17West Announces Second Quarter 2009 Results 53596 18West Announces Second Quarter 2009 Results 53596 19West Announces Second Quarter 2009 Results 53596 20Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer 53592 1Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer 53592 2Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer 53592 3Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer 53592 4Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer 53592 5
... March 24 NuRx,Pharmaceuticals, Inc. (OTC Bulletin Board: NURX) ... Phase I clinical trial of the first-in-class,rexinoid receptor (RXR) ... to complete in the fourth,quarter of this year, is ... NRX4204 is the company,s first drug candidate in clinical,trials., ...
... Lower systemic drug exposure observed compared to currently marketed ... ... MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP ) announced today ... demonstrated,lower systemic drug exposure when compared to the currently ...
Other Medicine Technology:NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204 2MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate 2MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate 3
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
Plate Roller...
Multi-Tier Shaker...
... bacterial growth system, combines orbital shaking, ... format for bacterial growth. It is ... HT-Prep™ Automatic DNA Extractor. The uniquely ... traditional floor shakers. Plate-holding cassettes allow ...
Medicine Products: